DOV
50
2
PNR
60
3
PCG
66
5
VNO
49
2
DHR
40
5
MCHP
37
3
OKE
67
5
M
48
2
KHC
15
4
HSY
34
3
WFC
60
2
SRE
47
7
TRV
42
5
HBI
56
3
SO
51
3
NAVI
40
7
IBM
54
3
GE
64
4
TRIP
66
2
EIX
62
3
DOV
50
2
PNR
60
3
PCG
66
5
VNO
49
2
DHR
40
5
MCHP
37
3
OKE
67
5
M
48
2
KHC
15
4
HSY
34
3
WFC
60
2
SRE
47
7
TRV
42
5
HBI
56
3
SO
51
3
NAVI
40
7
IBM
54
3
GE
64
4
TRIP
66
2
EIX
62
3
Financhill
Back

Emergent BioSolutions Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32

EBS
Emergent BioSolutions

Last Price:
$8.29
Seasonality Move:
-0.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Emergent BioSolutions Stock Forecast

  • Over the next 52 weeks, Emergent BioSolutions has on average historically risen by 31.1% based on the past 18 years of stock performance.
  • Emergent BioSolutions has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Emergent BioSolutions Stock Undervalued?
    The current Emergent BioSolutions [EBS] share price is $8.30. The Score for EBS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • EBS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Emergent BioSolutions Stock Go Up Next Year?

  • Over the next 52 weeks, Emergent BioSolutions has on average historically risen by 31.1% based on the past 18 years of stock performance.

Emergent BioSolutions Stock Rating

Sell
32
Emergent BioSolutions (EBS) is a Sell

Is Emergent BioSolutions overpriced?

  • Emergent BioSolutions has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Emergent BioSolutions Stock Price History

Is EBS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EBS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
emergentbiosolutions.com

52-Week Data

52-Week High:
15.10
52-Week Low:
1.42

Prediction Charts

Market Cap:
449.7M
Price in USD:
8.30
Volume:
536K
Beta:
0.85

Technical Analysis

SMA50:
9.24
SMA100:
8.74
SMA200:
7.15
52-Wk Change:
234.68%

Stock Predictions

  • Is Emergent BioSolutions stock public?
    Yes, Emergent BioSolutions is a publicly traded company.
  • What is the Emergent BioSolutions stock quote today?
    The Emergent BioSolutions stock price is 8.30 USD today.
  • How to buy Emergent BioSolutions stock online?
    You can buy Emergent BioSolutions shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 9.31 9.15 9.40 9.05
Dec-6 9.30 9.01 9.54 8.85
Dec-9 9.02 8.76 9.06 8.65
Dec-10 8.76 8.61 8.76 8.51
Dec-11 8.71 8.57 8.77 8.32
Dec-12 8.56 8.69 8.89 8.51
Dec-13 8.80 8.48 8.87 8.35
Dec-16 8.60 8.87 9.03 8.50
Dec-17 8.74 8.79 8.84 8.36
Dec-18 8.80 8.16 8.86 8.02
Dec-19 8.25 8.06 8.35 8.01
Dec-20 7.85 8.10 8.35 7.70
Dec-23 8.07 8.15 8.18 7.83
Dec-24 8.19 8.30 8.56 8.08

Emergent BioSolutions Earnings

Emergent BioSolutions Earnings Report: Per Share Emergent BioSolutions Earnings Q1 Q2 Q3 and Q4 last year and next year.

Emergent BioSolutions Forecast Revenue Growth

Emergent BioSolutions Stock Analysis: Historical quarterly revenues per share for Emergent BioSolutions and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.99 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.06 per share, and an increase next year of $2.88 per share.

* Emergent BioSolutions stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.